Back

dr. F.Y.F.L. (Filip) de Vos

dr. F.Y.F.L. (Filip) de Vos

Assistant Professor - medical

Show full profile

Research Output (111)

The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?

van der Hiel Bernies, Aalbersberg Else A, van den Eertwegh Alfons J M, de Wit-van der Veen Linda J, Stokkel Marcel P M, Lopez-Yurda Marta, Boellaard Ronald, Kapiteijn Ellen W, Hospers Geke A P, Aarts Maureen J B, de Vos Filip Y F L, Boers-Sonderen Marye J, van der Veldt Astrid A M, de Groot Jan Willem B, Haanen John B A G 19 Dec 2023, In: Clinical Nuclear Medicine. 49 , p. 138-145 8 p.

Practice variation in re-resection for recurrent glioblastoma:A nationwide survey among Dutch neuro-oncology specialists

van Opijnen Mark P, de Vos Filip Y F, Nabuurs Rob J A, Snijders Tom J, Nandoe Tewarie Rishi D S, Taal Walter, Verhoeff Joost J C, van der Hoeven Jacobus J M, Broekman Marike L D 1 Aug 2023, In: Neuro-Oncology Practice. 10 , p. 360-369 10 p.

Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)

Reijneveld Jaap C, Machingura Abigirl, Coens Corneel, Taphoorn Martin J B, Taal Walter, Clement Paul M, Idbaih Ahmed, de Vos Filip Y F, Klein Martin, Wick Wolfgang, Mulholland Paul J, Lewis Joanne, Golfinopoulos Vassilis, Ghislain Irina, Bottomley Andrew, van den Bent Martin J, 19 Jun 2023, In: European Journal of Cancer. 190 , p. 1-15

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer

Pruis Melinda A, Krebs Matthew G, Plummer Ruth, De Vos Filip, Angevin Eric, Prenen Hans, Forster Martin D, Clack Glen, Van der Aa Annegret, Tjwa Marc, Jansen Ellen, Perera Timothy, Lolkema Martijn P 1 Jun 2023, In: Oncologist. 28 , p. e1248-e1258

Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020)

Padilla C S, Ho V K Y, Mooijenkind T W A N, Louwman M W J, de Vos F Y F L, Bekkenk M W, Minnaard W A, Loef C, van Zanten S E M Veldhuijzen 12 May 2023, In: Journal of Neuro-Oncology. 163 , p. 239-248 10 p.

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer

van der Velden Naomi Cornelia Anna, Han Paul K J, van Laarhoven Hanneke W M, de Vos Filip Y F L, Hendriks Lizza E L, Burgers Sjaak A, Dingemans Anne-Marie C, van Haarst Jan Maarten W, Dits Joyce, Smets Ellen M A, Henselmans Inge 9 May 2023, In: Oncologist. 28 , p. e653-e668

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers:the phase 2 ROAR trial

Subbiah Vivek, Kreitman Robert J, Wainberg Zev A, Gazzah Anas, Lassen Ulrik, Stein Alexander, Wen Patrick Y, Dietrich Sascha, de Jonge Maja J A, Blay Jean-Yves, Italiano Antoine, Yonemori Kan, Cho Daniel C, de Vos Filip Y F L, Moreau Philippe, Fernandez Elena Elez, Schellens Jan H M, Zielinski Christoph C, Redhu Suman, Boran Aislyn, Passos Vanessa Q, Ilankumaran Palanichamy, Bang Yung-Jue 14 Apr 2023, In: Nature Medicine. 29 , p. 1103-1112 10 p.

Medulloblastoma in adults:evaluation of the Dutch society for neuro-oncology treatment protocol

Bleeker L, Kouwenhoven M C M, de Heer I, Lissenberg-Witte B I, Gijsbers A H, Dubbink H J, Kros J M, Gijtenbeek J M M, Kurt E, van der Rijt C C D, Swaak-Kragten A T, de Vos F Y, van der Weide H L, French P J, van den Bent M J, Wesseling P, Bromberg J E C 15 Mar 2023, In: Journal of Neuro-Oncology. 162 , p. 225-235 11 p.

Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy:a pre-posttest evaluation

Bos-van den Hoek D W, van Laarhoven H W M, Ali R, Bakker S D, Goosens A, Hendriks M P, Pepels M J A E, Tange D, de Vos F Y F L, van de Wouw A J, Smets E M A, Henselmans I Mar 2023, In: Supportive Care in Cancer. 31

Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment:A Secondary Analysis of a Randomized Trial

van de Water Loïs F, Bos-van den Hoek Danique W, Kuijper Steven C, van Laarhoven Hanneke W M, Creemers Geert-Jan, Dohmen Serge E, Fiebrich Helle-Brit, Ottevanger Petronella B, Sommeijer Dirkje W, de Vos Filip Y F, Smets Ellen M A, Henselmans Inge 2023, In: Medical Decision Making. 44 , p. 89-101 13 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not